logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12053524 B1

PDFFull Text
Date of Patent:
Aug. 06, 2024

Filed:

Aug. 13, 2021

Anti-podocalyxin antibodies and methods of using the same

Applicants:

Centre for Drug Research and Development, Vancouver, CA;

The University of British Columbia, Vancouver, CA;

Inventors:

Kelley Marshall McNagny, Vancouver, CA;

Calvin D. Roskelley, Vancouver, CA;

Michael R. Hughes, Vancouver, CA;

Diana Canals Hernaez, Vancouver, CA;

Klas Ola Blixt, Vintrie, SE;

John Stephen Babcook, Vancouver, CA;

Christopher John Bond, Mercer Island, WA (US);

Ismael Samudio, Vancouver, CA;

Jan Peter Bergqvist, Vancouver, CA;

Katherine Grace MacDonald, Vancouver, CA;

Anna Von Rossum, Vancouver, CA;

Bradley John Hedberg, Sooke, CA;

Pamela Megan Dean, Vancouver, CA;

Assignee:
Attorney:

Todd Lorenz

Primary Examiner:

Sheela J Huff

Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 35/17 (2015.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C12N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 35/17 (2013.01); A61K 47/6803 (2017.08); A61K 47/6809 (2017.08); A61K 47/6817 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61P 35/00 (2018.01); C07K 14/705 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 16/3076 (2013.01); C12N 5/10 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/622 (2013.01); C07K 2317/732 (2013.01); C07K 2317/92 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01); C07K 2319/41 (2013.01);
Abstract

The present invention is directed to anti-podocalyxin antibodies, compositions comprising the same, and methods of using such antibodies and compositions for the prevention, diagnosis and treatment of cancer.

Find Patent Forward Citations

Loading…